Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Director of Transverse Venture Capital Investments Division
Benoit Barteau Ph.D
Investment Director
Nicolas Berdou
Investment Director, Defense Expert
Clarisse Blandin
Investment Director
Elyssa Maufras du Châtellier
Investment Director
Edouard Combette
Investment Director
Charlotte Corbaz
Investment Drector - Large Venture
Nicolas Dardenne
Senior Investment Director, Normandy (Caen Rouen)
Arnaud Despoisse
Director of Occitanie Participations
Philippe Dutheil
Investment Director
Mailys Ferrere
Director of Large Venture Investments
Romain Fourcade
Investment Director
Paul-Francois Fournier
Executive Director, Innovation Department
Pierre Gillet
Investment Director
Vanessa Giraud
Director of Environmental Impact Funds
Alessandro Gonella
Director
Gwenael Hamon
Investment Director
Laurent Higueret
Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund
Louis Janneau
Investment Director and Fund Manager
Magali Joessel
Director of Funds
So-Yeon Koo
Senior Investment Manager
Jérôme Langlade
Investment Director Aquitaine / Limousin / Poitou-Charentes
Eric Lefebvre
Director
Stephane Lefevre-Sauli
Senior Investment Director
Arnaud Legardeur
Investment Director
Chahra Louafi
Senior Investment Director
Serge Mesguich
Director of FIT
Laure Michel
Investment Director
Louis Molis
Investment Director
Jean-Francois Morin
Investment Director
Sébastien Moynot
Director
Adrien Muller
Investment Director
Adrien Néel
Investment Director
Axel Piriou
Director of Investments
Olivier Rameil
Senior Investment Director / VC seed
Vincent Roque
Director
Thibaut Roulon Ph.D
Investment Director
Gilles Schang
Deputy Managing Director
Bruno Villeneuve
Associate
Jean-Marie Fougeray
Senior Investment Director, Brittany
Past deals in Laser
SteerLight
Debt Financing in 2024
SteerLight is a technology startup specializing in the development of LiDAR-based optical sensors. These sensors, which use laser light to measure distances and create 3D maps of their surroundings, are designed for long-range applications. SteerLight's innovative use of silicon photonics enables these sensors to provide enhanced perception, allowing clients to create more precise and cost-effective automated robotic systems.
Quandela
Series B in 2023
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Scintil Photonics
Venture Round in 2022
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.
Quandela
Venture Round in 2021
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Scintil Photonics
Seed Round in 2019
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.
Lewis Industries
Private Equity Round in 2015
Lewis Industries specializes in the design and manufacture of precision sheet metal parts, incorporating electronic components as necessary to deliver fully assembled equipment. Founded in 1966 and based in Nemours, France, the company serves various sectors including medical, lighting, information technology, telecommunications, heating, transport, and instrumentation. With over 40 years of experience, Lewis Industries is known for its expertise in high precision operations such as laser cutting, sheet metal bending, welding, assembly, and finishing. The company is committed to providing parts with both simple and complex geometries, as well as functional units tailored to the specific needs of its clients.
Technogenia
Venture Round in 2014
Technogenia specializes in tungsten carbide metallurgy, focusing on the manufacture of abrasion-resistant and anti-wear welding products and coatings. Utilizing high-power laser technology, the company aims to enhance hardness and durability in its offerings. Technogenia serves various industries, including oil and gas drilling, mining, and the iron and steel sector, providing solutions that effectively address abrasion challenges faced by its clients.
Nanobiotix
Grant in 2013
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Nanobiotix
Series E in 2013
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Nanobiotix
Seed Round in 2005
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Oxxius
Seed Round in 2002
Oxxius SA specializes in the development, design, manufacturing, and sale of diode-pumped solid-state lasers and laser diode modules. Founded in 2002 and headquartered in Lannion, France, the company produces a range of lasers including UV, visible, and infrared options, as well as ultra-stable and single longitudinal mode laser modules. These products serve various applications such as fluorescence analysis in flow cytometry and microscopy, interferometry in laser Doppler velocimetry and holography, and Raman spectroscopy. Oxxius's innovative laser technology offers significant advancements in compactness, reliability, and cost-efficiency, catering to both research and industrial markets. The company distributes its products through a network of partners across multiple countries, ensuring wide accessibility for its offerings in bio-photonics, metrology, and spectroscopy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.